Figure 1. FACS analysis of cynomolgus BDCA2 expression in CHO-K1/cyno BDCA2/cyno FcER1G cells. The CHO-K1/cyno BDCA2/cyno FcER1G cells (blue) and the negative control CHO-K1 cells (red) were probed using PE conjugated Anti-BDCA2 (Cat. No. 130-090-511, Miltenyi).

CHO-K1/cyno BDCA2 and FcER1G Stable Cell Line

Recombinant CHO-K1 cells stably overexpress cynomolgus C-type lectin domain family 4 member C (BDCA2) and Fc epsilon receptor Ig (FcER1G) on the surface. The surface expression of BDCA2 is validated by FACS analysis.

產品編號	M00594
規格	2 vials 大單詢價
數量
價格	詢價


聯系我們

產品簡介

Product Description	Recombinant CHO-K1 cells stably overexpress cynomolgus C-type lectin domain family 4 member C (BDCA2) and Fc epsilon receptor Ig (FcER1G) on the surface. The surface expression of BDCA2 is validated by FACS analysis.
Culture Properties	Adherent
Stability	Stable through more than 16 passages without significant changes in assay performance or expression profile.
Size	Two vials of frozen cells (>1×10⁶ per vial in 1 mL)
Storage	Store cells in liquid nitrogen immediately upon receipt. Thaw and recover cells within one year from the date received.

培養條件

Culture Medium	Ham’s F-12K (Kaighn’s), 10% FBS, 4 μg/ml Puromycin (Cat. No. A11138-03, Life Techonologies)
Complete Growth Medium	Ham’s F-12K (Kaighn’s) (Cat. No. 21127-022, Life Techonologies), 10% FBS (Cat. No. 10099-141, Life Techonologies)
Freeze Medium-DATA	95% complete growth medium, 5% (V/V) DMSO (Cat. No. D2650, Sigma)

圖例

Figure 1. FACS analysis of cynomolgus BDCA2 expression in CHO-K1/cyno BDCA2/cyno FcER1G cells. The CHO-K1/cyno BDCA2/cyno FcER1G cells (blue) and the negative control CHO-K1 cells (red) were probed using PE conjugated Anti-BDCA2 (Cat. No. 130-090-511, Miltenyi).

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.

国产精品久久久久久永久牛牛,55国产福利在线视频,成人午夜精品视频在线观看

CHO-K1/cyno BDCA2 and FcER1G Stable Cell Line

資源中心

技術支持

關于我們